282 related articles for article (PubMed ID: 20144748)
41. In vitro and in vivo evaluation of a novel oral insulin formulation.
Ma EL; Ma H; Liu Z; Zheng GX; Duan MX
Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747
[TBL] [Abstract][Full Text] [Related]
42. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
43. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
44. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
45. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
Wu J; Wei W; Wang LY; Su ZG; Ma GH
Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
[TBL] [Abstract][Full Text] [Related]
46. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
47. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
Nam K; Watanabe J; Ishihara K
Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
[TBL] [Abstract][Full Text] [Related]
48. Carboxymethyl β-cyclodextrin grafted carboxymethyl chitosan hydrogel-based microparticles for oral insulin delivery.
Yang Y; Liu Y; Chen S; Cheong KL; Teng B
Carbohydr Polym; 2020 Oct; 246():116617. PubMed ID: 32747257
[TBL] [Abstract][Full Text] [Related]
49. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
50. Transmucosal macromolecular drug delivery.
Prego C; García M; Torres D; Alonso MJ
J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
[TBL] [Abstract][Full Text] [Related]
51. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration.
Besheer A; Wood KM; Peppas NA; Mäder K
J Control Release; 2006 Mar; 111(1-2):73-80. PubMed ID: 16460830
[TBL] [Abstract][Full Text] [Related]
52. Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin.
Yin L; Ding J; Zhang J; He C; Tang C; Yin C
Biomaterials; 2010 Apr; 31(12):3347-56. PubMed ID: 20116843
[TBL] [Abstract][Full Text] [Related]
53. Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers.
Beck RC; Pohlmann AR; Hoffmeister C; Gallas MR; Collnot E; Schaefer UF; Guterres SS; Lehr CM
Eur J Pharm Biopharm; 2007 Aug; 67(1):18-30. PubMed ID: 17317124
[TBL] [Abstract][Full Text] [Related]
54. Development and characterization of in situ gel system for nasal insulin delivery.
Agrawal AK; Gupta PN; Khanna A; Sharma RK; Chandrawanshi HK; Gupta N; Patil UK; Yadav SK
Pharmazie; 2010 Mar; 65(3):188-93. PubMed ID: 20383938
[TBL] [Abstract][Full Text] [Related]
55. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2005 Jan; 101(1-3):111-25. PubMed ID: 15588898
[TBL] [Abstract][Full Text] [Related]
56. On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics.
Rana S; Gallo A; Srivastava RS; Misra RD
Acta Biomater; 2007 Mar; 3(2):233-42. PubMed ID: 17224313
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles.
Woitiski CB; Neufeld RJ; Veiga F; Carvalho RA; Figueiredo IV
Eur J Pharm Sci; 2010 Nov; 41(3-4):556-63. PubMed ID: 20800679
[TBL] [Abstract][Full Text] [Related]
58. Alginate microparticles as novel carrier for oral insulin delivery.
Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
[TBL] [Abstract][Full Text] [Related]
59. Novel PVA-based hydrogel microparticles for doxorubicin delivery.
Cavalieri F; Chiessi E; Villa R; Viganò L; Zaffaroni N; Telling MF; Paradossi G
Biomacromolecules; 2008 Jul; 9(7):1967-73. PubMed ID: 18533701
[TBL] [Abstract][Full Text] [Related]
60. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
